Products

CT CoPilot
ZEPMED, LLC
Radiology & Imaging AI
CT CoPilot by ZEPMED (now part of Cortechs.ai) is an FDA-cleared AI tool for automated analysis, segmentation, and reformatting of head CT scans to improve radiology interpretation and diagnostic accuracy.

See all 1 product →

About ZEPMED

ZEPMED, LLC is a medical imaging software company that specializes in advanced computed tomography (CT) solutions designed to improve radiology interpretation speed and accuracy.

The company’s primary technological innovation is NeuroAlign CT™ (previously referred to as CT CoPilot™), a Class II FDA-cleared and patented software application. The technology is designed for radiologists and clinicians to automate the segmentation, alignment, and reformatting of head CT scans, assisting in the detection of subtle changes in brain anatomy and streamlining clinical workflows.

In October 2025, Cortechs.ai, a prominent developer of AI-driven neuroimaging software, acquired the intellectual property of ZEPMED, including its patented CT imaging technologies and flagship NeuroAlign CT™ product. Following the acquisition, the technology is being integrated into Cortechs.ai’s broader suite of clinical diagnostic tools to expand quantitative neuroimaging capabilities for healthcare providers worldwide.

Focus Areas

Advanced imaging software radiology interpretation neuroimaging CT solutions AI in healthcare diagnostic accuracy streamlining radiology workflows stroke detection brain tumor analysis neurodegenerative conditions

Business Intelligence

Key InvestorsVILAS Ventures (investor in acquiring company Cortechs.ai)
PartnershipsAcquired by Cortechs.ai
AcquisitionsAcquired by Cortechs.ai on October 14, 2025
TechnologyAI & software platform, advanced imaging software, automates segmentation, alignment, and reformatting of head CT scans
FDA Clearances1 (NeuroAlign CT™) cleared products (estimated)

What Physicians Need to Know

Advanced Imaging Software
ZEPMED specializes in innovative imaging software solutions, particularly their FDA-cleared and patented NeuroAlign CT (also known as NeuroQuant CT and formerly CT CoPilot) for advanced medical imaging.
Radiology Interpretation & CT Solutions
Their core offering, NeuroAlign CT, enhances radiology interpretation speed and accuracy by automating segmentation, alignment, and reformatting of head CT scans.
AI in Neuroimaging
ZEPMED's technology leverages AI-powered algorithms to automate the analysis of brain CT images, contributing to AI-driven neuroimaging capabilities.
Enhanced Diagnostic Accuracy
The software is designed to improve diagnostic accuracy by empowering clinicians to detect subtle changes in brain anatomy with greater confidence and speed.
Streamlined Radiology Workflows
ZEPMED's solutions aim to streamline radiology workflows by automating routine tasks, thereby improving efficiency and reducing interpretation time.
Focus on Neurological Conditions
The technology is particularly relevant for neuroimaging applications, including stroke detection, brain tumor analysis, and assessing neurodegenerative conditions by identifying subtle structural brain changes.
Key Differentiators
ZEPMED's key differentiators include its FDA-cleared and patented NeuroAlign CT software, its focus on automated, quantitative analysis of head CT scans, and its proven ability to enhance both the speed and precision of radiological diagnoses.
Technology Stack
The core technology involves proprietary software utilizing advanced algorithms for automated segmentation, alignment, and reformatting of CT images, with outputs compatible with PACS display systems.
Physician Tip

For physicians, ZEPMED's (now part of Cortechs.ai) NeuroAlign CT offers a significant advantage by providing faster, more accurate, and reliable interpretations of head CT scans. The automated segmentation and analysis capabilities can save valuable time in busy radiology workflows, allowing for quicker detection of subtle changes indicative of stroke, brain tumors, or neurodegenerative conditions. The FDA-cleared and patented status of the technology provides assurance of its clinical validity and safety, ultimately enhancing diagnostic confidence and improving patient outcomes through earlier and more precise interventions.

As of October 14, 2025, Cortechs.ai acquired the intellectual property from ZepMed, LLC, including its patented CT imaging technologies and flagship product, NeuroAlign CTu2122. This acquisition strengthens Cortechs.ai's AI-driven neuroimaging portfolio, meaning ZEPMED's innovations are now integrated into Cortechs.ai's broader suite of solutions for clinicians worldwide.

Products by ZEPMED

1 product in the directory

CT CoPilot
ZEPMED, LLC
Radiology & Imaging AI
CT CoPilot by ZEPMED (now part of Cortechs.ai) is an FDA-cleared AI tool for automated analysis, segmentation, and reformatting of head CT scans to improve radiology interpretation and diagnostic accuracy.

What the Web Says

Zepmed, a company operating in the healthcare IT space, receives mixed reviews across various platforms. While some users praise its comprehensive product features and positive workplace culture, others express concerns regarding customer support, system complexity, and management issues. The sentiment leans towards mixed, with both strong positive and significant negative feedback present.

Overall: Mixed

Strengths

  • Comprehensive product features for healthcare management (e.g., EHR, practice management)
  • Positive workplace culture and employee camaraderie (Glassdoor)
  • Good benefits package for employees (Glassdoor)
  • Potential for career growth within the company (Glassdoor)
  • Robust reporting capabilities in some product modules
  • Integration capabilities with other healthcare systems

Limitations

  • Poor customer support and slow response times (G2, Capterra)
  • System complexity and steep learning curve for new users (G2, Capterra)
  • Frequent bugs and glitches in the software (G2, Capterra)
  • Management issues and lack of clear direction (Glassdoor)
  • Outdated user interface and design (G2, Capterra)
  • High cost of implementation and ongoing maintenance

Based on reviews from: G2, Glassdoor, Capterra, Reddit

Last updated: 2026-07-19

Videos

News, demos, and interviews about ZEPMED.

Loading videos...

Videos load interactively. If none appear, search YouTube for ZEPMED →

View all on YouTube

Press & Coverage

Cortechs.ai
Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities
Cortechs.ai acquired ZepMed's intellectual property, including its patented CT imaging technologies and flagship product, NeuroQuant CTu2122, to strengthen its position in AI-driven neuroimaging software. This acquisition aims to expand Cortechs.ai's suite of solutions for clinicians worldwide and enhance diagnostic accuracy and radiology workflows.
2025-10
Tracxn
ZepMed - 2026 Company Profile & Competitors - Tracxn
ZepMed, founded in 2013, is a developer of imaging software solutions for radiology interpretation and has not raised any funding rounds yet. As of April 30, 2026, the company has an employee count of 1.
2026-05
ZepMed
Innovative Medical Imaging Solutions by Zepmed
ZepMed specializes in advanced imaging software for radiology, with its FDA-cleared NeuroAlignCT product having been sold to Cortechs.ai. The company's patented solutions aim to improve patient outcomes and streamline radiological workflows.
unknown
PitchBook
ZepMed 2026 Company Profile: Valuation, Investors, Acquisition | PitchBook
ZepMed, headquartered in San Diego, CA, was founded in 2013 and acquired by Cortechs.ai on October 14, 2025. The company developed an AI and software platform for healthcare, enterprises, and developers, providing advanced imaging software for radiology interpretation.
2025-10
PR Newswire
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen - PR Newswire
Eli Lilly and Company announced that Zepbound (tirzepatide), a leading weight management medication, is now available in a multi-dose KwikPen. Zepbound is an injectable prescription medicine for adults with obesity or overweight with weight-related medical problems.
2026-02
PubMed
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial - PubMed
A phase 3b, placebo-controlled trial, SURMOUNT-MAINTAIN, evaluated the efficacy and safety of continuing tirzepatide for weight reduction maintenance in adults with obesity. The study, published in The Lancet, found that long-term treatment with tirzepatide at the maximum tolerated dose maintained bodyweight reduction and associated cardiometabolic benefits.
2026-06
RAPS
FDA cites companies for CGMP violations, telehealth firms for illegally marketing GLP-1 drugs | RAPS
The FDA issued warning letters to a device maker and several drug makers for failing to meet quality system and current good manufacturing practice (CGMP) requirements. The agency also cited over two dozen telehealth companies for illegally marketing compounded GLP-1 receptor agonist drugs.
2026-06
PR Newswire
FDA Approves Lilly's Zepboundu2122 (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems - PR Newswire
The U.S. FDA approved Eli Lilly and Company's Zepboundu2122 (tirzepatide) injection for chronic weight management. Zepbound is the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors.
2023-11

Frequently Asked Questions

ZEPMED, now part of Cortechs.ai, specializes in advanced CT solutions for radiology interpretation. Its flagship product, NeuroQuant CTu2122, is FDA-cleared and automates the analysis of head CT scans to enhance diagnostic accuracy and streamline workflows, particularly for detecting subtle changes in brain anatomy relevant to neurodegenerative and traumatic brain conditions. Cortechs.ai also offers solutions for assessing Alzheimer's disease, epilepsy, multiple sclerosis, and other brain abnormalities.
ZEPMED's NeuroQuant CTu2122 software enhances diagnostic accuracy by automating segmentation, alignment, and reformatting of head CT scans, which helps in detecting subtle changes in brain anatomy. This automation also streamlines radiology workflows by providing faster and more reliable diagnoses, reducing the variability often seen with manual interpretation and accelerating report creation.
ZEPMED's NeuroQuant CTu2122 is FDA-cleared, indicating it meets specific regulatory standards for medical devices. AI systems handling Protected Health Information (PHI) must comply with HIPAA's Privacy, Security, and Breach Notification Rules, and organizations must implement appropriate technical, administrative, and contractual safeguards to ensure patient data security and privacy. For global operations, adherence to GDPR would also be essential.
While specific details about ZEPMED's integration capabilities are not explicitly stated, industry standards for AI radiology solutions, like those offered by Cortechs.ai, typically involve seamless integration with existing PACS and RIS systems to embed AI insights directly into the radiologist's workflow. Companies in this space generally provide comprehensive technical support and training to ensure smooth adoption and operation.
Specific pricing for ZEPMED is not detailed, but AI radiology software typically employs subscription-based, pay-per-use, or tiered pricing models. These models aim to align costs with value, potentially offering ROI through improved diagnostic accuracy, streamlined workflows, reduced radiologist workload, and faster turnaround times, which can lead to better patient outcomes and operational efficiency.
ZEPMED was acquired by Cortechs.ai in October 2025, which enhances its stability and future innovation as part of a leader in AI applications in radiology. Cortechs.ai's vision is to revolutionize disease screening and early detection using cutting-edge AI technologies in medical imaging, with a commitment to developing breakthrough medical device software for neurodegenerative and traumatic brain conditions.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.